Substance / Medication

Methanthelinium

Overview

Active Ingredient
methantheline
RxNorm CUI
6821

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

47 trials linked to this intervention

47
Total Trials
11
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Cholecystectomy for suspected gallbladder dyskinesia.
Gurusamy Kurinchi Selvan, Junnarkar Sameer, Farouk Marwan et al. · Cochrane Database Syst Rev · 2009
PMID: 19160318Meta-AnalysisFull text (PMC)
Surgical therapy for biliary dyskinesia: a meta-analysis and review of the literature.
Ponsky Todd A, DeSagun Robert, Brody Fredrick · J Laparoendosc Adv Surg Tech A · 2005
PMID: 16185113Meta-Analysis
[The occurrence of gallbladder contractility disorders in children with some diseases presenting as abdominal pain].
Czkwianianc Elzbieta, Raczyński Piotr, Kubińska Izabela et al. · Pol Merkur Lekarski · 2009
PMID: 19606688RCT
The use of tenoten preparation in complex therapy of hypomotoric biliary dyskinesia.
Simanenkov V I, Poroshina E G, Tikhonov S V · Bull Exp Biol Med · 2009
PMID: 20027368RCT
[Assessment of the efficacy of mebeverine in the complex therapy of chronic noncalculolis cholecystitis and biliary dysfunction].
Maev I V, Samsonov A A, Ul'iankina E V et al. · Eksp Klin Gastroenterol · 2007
PMID: 17539356RCT
[Vegetotropic therapy and hypobaric hypoxic adaptation in gallbladder motor dysmotility].
Nikolaeva A G, Girsa V N, Nemtsov L M · Eksp Klin Gastroenterol · 2007
PMID: 17939194RCT
Successful treatment of cholinergic urticaria with methantheliniumbromide.
Altrichter Sabine, Wosny Katja, Maurer Marcus · J Dermatol · 2015
PMID: 25571938Case Report
Characterization of methanthelinium binding and function at human M-Mmuscarinic acetylcholine receptors.
Irmen Matthias, Holze Janine, Bödefeld Theresa et al. · Naunyn Schmiedebergs Arch Pharmacol · 2018
PMID: 29938305Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Methantheline (substance)
SNOMED CT
2796008
UMLS CUI
C0025624
RxNorm CUI
6821

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

4
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
47
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.